reach their optimal growth. Traditionally, Fe is supplemented into diets in the form of inorganic salts, such as sulfates and oxides. However, inorganic Fe additives have many disadvantages, such as low bioavailability, high hydroscopicity and oxidation, high excretion, and so on. In recent years, organic Fe products, especially complexes or chelates of Fe with amino acids or hydrolyzed protein, have been developed as alternatives to traditional inorganic Fe sources. In the present study, we evaluated the relative bioavailability of a new form of organic Fe (Fe proteinate), which is a chelate of Fe with amino acids and small peptides produced from hydrolyzed protein. The bioavailability of this Fe proteinate is unknown. The bioavailability comparison has been commonly used to evaluate the effectiveness of organic Fe products. However, it was been reported that the efficacy of organic Fe products in animals, compared with inorganic Fe, was not consistent. In some early studies, organic Fe sources were more available than inorganic Fe sources (Spears et al., 1992; Yu et al., 2000) , whereas others reported that there was no difference in bioavailability between the 2 kinds of Fe sources, or the organic Fe sources were even less available than inorganic Fe sources (Lewis and Miller, 1995; Cao et al., 1996) .
The above inconsistency may be related to the quality of organic Fe sources, the indices and method of Fe bioavailability evaluations, or the type of basal diets used in studies. First, the quality of organic Fe sources, the degree or strength of chelation or complexation of Fe ion to organic ligands is an important factor affecting the bioavailability of organic Fe. It has been reported that the quality of organic mineral sources was related to the stabilization and absorption of organic mineral sources in the gut (Ashmead et al., 1985) , which made them different in bioavailability. Series of studies from our laboratory have demonstrated that intestinal absorptions, target tissue utilizations, and bioavailabilities of organic Mn (complexes or chelates with amino acids, small peptides, or both) in broilers, organic Zn (complexes or chelates with amino acids, small peptides, or both) in broilers, or the organic Cu (a chelate with amino acids and small peptides) in broilers were closely related with their strengths of chelation or complexation (Li et al., 2004 (Li et al., , 2011 Luo et al., 2007; Huang et al., 2009; Yu et al., 2010; Bai et al., 2012; Liu et al., 2012) .
In an early study, Elvehjem and Hart (1929) demonstrated that the anemia in chicks could be corrected by the addition of Fe to a purified basal diet. In the animal body, the status of Fe is mainly expressed by the concentration of hemoglobin (Hb) in the blood (Davis et al., 1968) . Traditionally, Hb concentration and hematocrit have been used for evaluating Fe nutritional status of animals, and several early studies demonstrated that Hb concentration and hematocrit were significantly affected by different Fe levels in diets, and increased as dietary Fe increased (Miltenburg et al., 1991; Strube et al., 2002; Rincker et al., 2004) . Recently, a total body Hb Fe calculated based on Hb concentration and blood volume has been shown to be a good index for evaluating Fe nutritional status of poultry . Liver is the main site for Fe metabolism for almost all animals (Graham et al., 2007) . Iron concentrations in liver and kidney have been shown to be changed by different Fe levels in diets (Cao et al., 1996) . Therefore, the above 4 indices might be sensitive for evaluating Fe bioavailabilities. In the past, a practical corn-soybean meal basal diet supplemented with excessive but not toxic levels of Fe was used in most studies to estimate the relative bioavailabilities of organic Fe products (Spears et al., 1992; Lewis and Miller, 1995; Yu et al., 2000) . However, high levels of Fe in diets might cause abnormal physiological status of animals and underestimation of Fe bioavailabilities. Therefore, it is necessary to use purified or semipurified diets supplemented with low levels of Fe to evaluate the relative bioavailability of organic Fe for animals. The objective of this study was to estimate the relative bioavailability of the organic Fe proteinate compared with inorganic Fe sulfate for broilers fed a purified casein-dextrose diet based on the aforementioned 4 indices.
MATERIALS AND METHODS

Experimental Design and Treatments
A completely randomized design involving a 2 × 3 factorial arrangement of treatments plus one control treatment was used in this experiment. Two supplemental Fe sources were Fe sulfate and Fe proteinate, respectively. The 3 supplemental Fe levels were 10, 20, or 40 mg of Fe/kg of diet. The 2 Fe sources shared one Fe-unsupplemented basal diet control; therefore, there were a total of 7 treatments in this experiment.
Birds
All experimental procedures were approved by the Office of the Beijing Veterinarians (Li et al., 2011) . A total of 448 one-day-old Arbor Acres commercial male chicks were randomly allotted to 1 of 7 treatments with 8 replicate cages of 8 birds each according to the abovementioned experimental design based on BW. Broilers were housed in electrically heated, thermostatically controlled room with fiberglass feeders, and stainlesssteel cages coated with plastics, and maintained on a 24-h constant light schedule for 14 d. Feed and distilleddeionized water were available ad libitum. There was no detectable Fe in the distilled-deionized water. Feed consumption and BW gain of chicks in each replicate cage were recorded at the end of every week. However, whenever a bird was found dead, the feed for the cage of the dead bird was immediately weighed. According to the initial feed weight and the last weight for the cage of dead bird, the feed intake of the dead bird could be calculated and deducted from the final feed intake of the cage of the dead bird.
Diets
The casein-dextrose basal diet (Table 1 , containing 4.56 mg of Fe/kg by analysis) was formulated to meet or exceed the nutrient requirements of starter broilers (NRC, 1994) except for Fe. The Fe sources were added to the basal diet according to the above experimental treatments. The Fe sulfate was reagent grade and supplied by Beijing Chemical Company, and its purity was more than 99.0%. The Fe proteinate was supplied by Alltech Inc., Nicholasville, Kentucky, and its purity was about 90%. The value of quotient of formation (Q f value) of Fe proteinate was analyzed to be 43.6; therefore, it was an organic Fe product with the moderate chelation strength based on the classification of Holwerda et al. (1995) . Variable small amounts of l-lysine monohydrochloride or d-, l-methionine were added to respective experimental diets according to the amounts of lysine and methionine from Fe proteinate to keep all 7 treatment diets containing equal levels of lysine and methionine. The analyzed Fe concentrations of diets were listed in Table 2 .
Sample Collections and Preparations
The feed ingredients and diet samples from all the treatments were taken and submitted for CP, Ca, P, and Fe analyses before the initiation of the trial to confirm CP, Ca, P, and Fe contents in diets. The Fe proteinate was sampled for analyses of Fe, amino acids, and Qf value. At 14 d of age, after fasting 8 h, 3 to 5 chicks were chosen from each of 56 cages according to average BW. They were bled by heart puncture with heparinized syringe equipped with stainless-steel needles for whole blood collection and stored at 4°C. The birds were subsequently killed and their liver and kidney samples were taken and frozen at −20°C. Samples were pooled together based on replicate cage. Whole blood samples were used for the analyses of Hb concentration and hematocrit, and liver and kidney samples were analyzed for Fe concentrations.
Sample Analyses
The concentrations of Fe in Fe source, diet, liver, and kidney samples were measured by inductively coupled plasma emission spectroscope (model IRIS Intrepid II, Thermal Jarrell Ash, Waltham, MA) after wet digestions with HNO 3 and HCIO 4 as described by Huang et al. (2009) . Concentrations of CP in feed ingredient or diet samples were determined as described by AOAC (1990) . Amino acids of Fe proteinate were analyzed using an amino acid analyzer (model L-8500A, Hitachi, Chyoudaku, Japan). The Q f value of Fe proteinate was determined by polarography as described by Li et al. (2004) and Huang et al. (2009) . Hemoglobin concentration and hematocrit were tested by an automatic hematology analyzer (ABX Pentra DF 120, Montpellier, France). The total body Hb Fe was calculated from Hb concentrations and estimates of blood volume based on BW (a blood volume of 85 mL per kg of BW is assumed): total body Hb Fe (mg) = BW (kg) × 0.085 L of blood/kg × Hb (g/L of blood) × 3.35 mg of Fe/g of Hb (Sturkie, 2000; Tako et al., , 2011 Tako et al., , 2013 .
Statistical Analyses
To test the effect of Fe supplementation, data were analyzed using single degree of freedom contrast to compare all supplemental Fe treatments with the control (Li et al., 2011) . Data excluding the control were (Littell et al., 1997) . Slope ratio and SE were estimated using the method of error propagation as described by Littell et al. (1995) . Difference between sources was determined by difference in their respective regression coefficients (Littell et al., 1995) . The P < 0.05 was considered to be statistically significant. Table 3 , and there were 1.09% lysine and 0.48% methionine in this organic Fe source.
RESULTS
Fe Contents in the 2 Fe Sources and Treatment Diets and Amino Acid Contents of Fe Proteinate
Growth Performance of Broilers
Data are listed in Table 4 . Compared with the control chicks, chicks fed Fe-supplemented diets had higher (P < 0.003) ADG and ADFI and lower feed conversion ratio (F:G; P = 0.02) and mortality (P < 0.003). The Fe source and the interaction between Fe source and added Fe level did not affect (P > 0.11) ADG, ADFI, F:G, and mortality. However, except for F: G (P = 0.14), the other 3 indices were affected (P < 0.0001) by added Fe level. As dietary Fe levels increased, ADG and ADFI increased linearly (P < 0.0001), whereas mortality decreased linearly (P < 0.0001).
Hemoglobin, Hematocrit, Total Body Hb Fe, and Fe Concentrations in Liver and Kidney
Data are listed in Table 5 . Compared with the control chicks, chicks fed Fe-supplemented diets had higher (P < 0.002) Hb concentration, hematocrit, total body Hb Fe, and Fe concentrations in both liver and kidney. No interactions (P > 0.21) between Fe source and added Fe level were observed in Hb concentration, hematocrit, total body Hb Fe and liver Fe concentration, except for kidney Fe concentration (P = 0.0090). There were no differences (P > 0.35) in kidney Fe concentration among 10, 20, or 40 mg/kg of added Fe as FeSO 4 •7H 2 O; however, the addition of 40 mg/kg of Fe as Fe proteinate increased (P < 0.0002) kidney Fe concentration compared with that of 10 or 20 mg/kg of Fe as Fe proteinate. Added Fe level affected (P < 0.0001) all of these 5 indices. As added Fe levels increased, all the aforementioned 5 indices increased linearly (P < 0.0001). The Fe source did not affect (P > 0.10) hematocrit and Fe concentrations in liver and kidney, but affected (P < 0.004) Hb concentration and total body Hb Fe. The birds fed the diets supplemented with Fe proteinate had higher (P < 0.004) Hb concentration and total body Hb Fe than those fed the diets supplemented with Fe sulfate.
Relative Bioavailability Estimate of Fe Proteinate
Regressions were calculated based on daily dietary analyzed Fe intake during the experimental period (Table 6). Significant (P < 0.0001) multiple linear regression relationships were observed in all 5 indices, so the relative bioavailability values were estimated based on them on daily dietary analyzed Fe intake (Table 7) . When the response to Fe sulfate was set at 100%, the estimated relative bioavailability of Fe proteinate were 117, 114, 103, 95.8, and 100% for Hb concentration, total body Hb Fe, hematocrit, and Fe concentrations in liver and kidney, respectively. However, there was only significant differences (P < 0.009) in Fe bioavailabilities based on Hb concentration and total body Hb Fe between Fe proteinate and Fe sulfate. Therefore, in enhancing Hb concentration and total body Hb Fe, the Fe from Fe proteinate was more available to broilers than that from Fe sulfate. 
DISCUSSION
Iron deficiency is the prevalent nutrient deficiency all over the world (Stoltzfus, 2001) , and exists not only in humans but also in animals. There are numerous experiments in which poultry have been taken as the model for studying Fe bioavailability; however, in general, it is often used to evaluate foods, food combina- tions, and factors within diets that can help to prevent Fe-deficient anemia . Moreover, Hb depletion and repletion assays have traditionally been used to assess Fe bioavailability for broilers (Aoyagi and Baker, 1995) . In the current study, we chose Hb concentration, hematocrit, and total body Hb Fe as the evaluation indices because they have been proved to be the sensitive indices for evaluating Fe deficiency, and these 3 indices increased as added dietary Fe levels increased (Chausow and Czarnecki-Maulden, 1988; Biehl et al., 1997; Tako et al., 2013) . The same results were also observed in the present study. However, Hb concentration and total body Hb Fe were significantly higher in the chicks fed the diets supplemented with Fe proteinate than in those fed the diets supplemented with Fe sulfate. Furthermore, based on Hb concentration and total body Hb Fe, the relative bioavailability values of the Fe proteinate were approximate, suggesting that these 2 indices were equally sensitive for estimating the bioavailabilities of Fe sources. Hemoglobin concentration and hematocrit have been authentically proved to be the effective indices for determining relative bioavailabilities of organic Fe sources. Total body Hb Fe could be affected by dietary Fe level , but it has not been reported to be used to estimate bioavailabilities of different Fe sources. Galdi and Bassi (1988) reported that when inorganic source (FeSO 4 •7H 2 O) was set as 100%, the relative bioavailability of organic Fe as Fe glycinate was 90% for rat based on Hb concentration. Rodents appeared to be much more efficient in Fe absorption from foods relative to human and birds (Patterson et al., 2008) . However, with the same index, the bioavailability of another organic Fe as Fe methionine for nursing pigs was 83% higher than that of Fe from FeSO 4 •7H 2 O (Spears et al., 1992) . Kuznetsov (1987) reported that the relative bioavailability of Fe in Fe methionine was 103% for 26-d-old pigs based on erythrocyte counts. In this study, based on Hb concentration and hematocrit, the relative bioavailabilities of Fe proteinate were 117 and 103%, respectively, which agreed with the early research, and based on total body Hb Fe, it was 114%. These results suggested that Hb concentration and total body Hb Fe might be more sensitive than hemato- crit in estimating the bioavailabilities of Fe sources for animals. The bioavailability of trace minerals was defined as the proportion of an ingested element that is absorbed, transported to its site of action, and converted to a physiologically active form (Matsui et al., 1996) . Therefore, for assessment of bioavailability, target tissue accumulation of trace minerals has been considered to be a sensitive criterion. For almost all animals, liver is the main site of Fe metabolism; therefore, liver Fe has been used as the criterion for bioavailability assays to compare different Fe sources and Fe levels. Cao et al. (1996) reported that Fe concentrations in liver and kidney increased linearly as added dietary Fe concentrations increased. Based on multiple linear regression of log 10 liver Fe concentration on total analyzed dietary Fe concentrations, the bioavailability value of Fe methionine was 88.3% relative to Fe sulfate which was set at 100% when chicks were fed corn-soybean meal diets (containing 188 mg of Fe/kg) supplemented with 400, 600, or 800 mg of Fe/kg (Cao et al., 1996) . In the last decades, in most studies on the bioavailabilities of organic Fe sources, pigs have been used as the experimental animals and broilers were rarely used. In a similar study, Yu et al. (2000) reported that in improving the Fe concentration in the liver of weanling pigs, the Availa Fe (a kind of Fe-amino acid complex, Zinpro Corp., Eden Prairie, MN) was more effective than Fe sulfate. However, Ammerman (1995) found that the bioavailability of Fe methionine was lower than that of Fe sulfate. From the early studies, it is well known that liver and kidney Fe concentrations were suitable for evaluating the relative bioavailability of organic Fe. Consequently, both indices were used in this study. However, these 2 indices were not sensitive enough to detect the difference in Fe bioavailability between 2 Fe sources, suggesting that the above 2 indices might not be suitable for Fe bioavailability assays in broilers. The exact reasons for that are not clear.
The chelation strength of an organic mineral source and its behavior under physiological conditions are perceived as key points in determining the value of product used as a supplement in animal nutrition (Huang et al., 2009 ). In the current study, the Fe proteinate with moderate chelation strength had a significantly higher relative bioavailability than inorganic Fe sulfate, which was consistent with our previous similar studies on organic Mn or Zn in broilers (Li et al., 2004 (Li et al., , 2011 Huang et al., 2009 Huang et al., , 2013 . Series of studies with broilers in our laboratory have demonstrated that the organic Mn or Zn sources with moderate chelation strengths had the highest relative bioavailabilities, and the organic Mn or Zn or Cu sources with weak chelation strengths were as available as their inorganic sulfate forms; however, the organic Zn source with very strong chelation strength was significantly less available than the inorganic Zn sulfate (Li et al., 2004 (Li et al., , 2011 Huang et al., 2009; Liu et al., 2012) . The above results might be explained by either the different modes of absorption of organic and inorganic Mn or Zn or Cu in the gut of broilers or their different utilizations in the target tissues, or both. As for absorption modes of organic trace elements in the gut of animals, 2 hypotheses were reported by Ashmead (1993) . One hypothesis is that the organic mineral complex or chelate with the optimal chelation strength could prevent the interference factors in the digestive tract and reach the intestinal brush border, directly, where it is hydrolyzed and absorbed as an ion into the blood, resulting in a higher bioavailability than the inorganic form. The other is that it could arrive at the absorptive site in the small intestine as an intact structure, rendering superior bioavailability to inorganic sources. Our recent studies in broilers have indicated that the organic Mn or Zn sources with moderate chelation strengths displayed significantly better Mn or Zn absorptions and target tissue utilizations than their inorganic sulfate forms (Li et al., 2008; Yu et al., 2010; Bai et al., 2012; Shen et al., 2013) . However, it is unclear whether the Fe proteinate with moderate chelation strength used in the present study had better Fe absorption or target tissue utilization or both than the inorganic Fe sulfate and how it was metabolized in broilers. Therefore, further studies in broilers are needed to elucidate the above questions.
In conclusion, the results from the present study indicated that for broiler chicks fed a casein-dextrose diet, the Fe proteinate with moderate chelation strength was significantly more available than inorganic Fe sulfate in enhancing Hb concentration and total body Hb Fe.
